WNPR

medicine

Ernesto del Aguila III, National Human Genome Research Institute (NHGRI) / Creative Commons

Researchers in Connecticut and nationwide are having a hard time recruiting minorities for clinical trials.

This hour, we find out why and we examine the impact on our health. Does mistrust of doctors and drug companies play a part?

allenallen1910 / Creative Commons

More and more, medical professionals in Connecticut are turning to tablets and cell phones to connect remotely with patients. It’s called “telehealth,” and it’s facilitating everything from after-hours examinations to post-surgery check-ins.

In 2010, Sonia Vallabh watched her mom, Kamni Vallabh, die in a really horrible way.

First, her mom's memory started to go, then she lost the ability to reason. Sonia says it was like watching someone get unplugged from the world. By the end, it was as if she was stuck between being awake and asleep. She was confused and uncomfortable all the time.

"Even when awake, was she fully or was she really? And when asleep, was she really asleep?" says Sonia.

Markus Spiske / Creative Commons

Lawmakers continue to debate health care policy in Washington, and millions wonder if they’ll be insured in the future.

This hour, we consider the impact here at home.

iStock

A genetic test that helps doctors determine how best to treat breast cancer -- and whether chemotherapy is likely to help -- is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.

Pages